SEC Form 4 · accession 0001209191-15-032086
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell H. Finer
Officer — Chief Scientific Officer
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 11:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | M | 30,000 | $2.0864 | A | 30,000 | D | |
| Common StockF2 | Apr 1, 2015 | S | 10,941 | $116.5406 | D | 19,059 | D | |
| Common StockF3 | Apr 1, 2015 | S | 4,245 | $117.3949 | D | 14,814 | D | |
| Common StockF4 | Apr 1, 2015 | S | 6,231 | $118.587 | D | 8,583 | D | |
| Common StockF5 | Apr 1, 2015 | S | 8,491 | $119.5384 | D | 92 | D | |
| Common Stock | Apr 1, 2015 | S | 92 | $120.17 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $2.0864 | Apr 1, 2015 | M | 30,000 | D | — | Jul 13, 2021 | Common Stock | 30,000 | 2,939 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
- F2The range of prices for the transaction reported on this line was $116.00 to $116.9850. The average weighted price was $116.5406. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $117.01 to $118.01. The average weighted price was $117.3949. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $118.02 to $118.92. The average weighted price was $118.5870. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $119.15 to $120.13. The average weighted price was $119.5384. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6This option vests at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter.